Both GPC and PCho are confirmed elevated in tumor tissue compared to adjacent non-involved tissue from breast cancer patients [17], and a higher GPC/PCho-ratio has been reported in ER negative tumors [34, 35]. This evidence concerns the gene ESR1 and neoplasm.